Vancomycin 50 MG/ML Oral Solution — RxCUI 2000134
RxNorm drug concept · Semantic clinical drug
RxCUI 2000134
Semantic clinical drug · SCD
● Current RxNorm concept 18 FDA products
26 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2000134
Official nameVancomycin 50 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asvancomycin 250 MG per 5 ML Powder for Oral Solution; vancomycin (as vancomycin hydrochloride) 50 MG/ML Oral Solution; vancomycin 15 GM per 289 ML Powder for Oral Solution; vancomycin 7.5 GM per 145 ML Powder for Oral Solution
FDA products mapped18
Package NDCs mapped26
Reported Medicaid activity (SDUD)3,050 prescriptions · 22 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Vancomycin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- When vancomycin is given by IV, it gets directly into your bloodstream and reaches infections in your blood, heart, bones, lungs, or skin. When it's swallowed, it mostly stays in y...
- Why am I getting vancomycin by IV instead of taking a pill?
- The most common thing people notice is flushing, redness, or itching on the face, neck, and upper chest — especially if the infusion runs too fast. This is sometimes called 'Red Ma...
- What should I watch for during my vancomycin infusion?
🕸️ Concept Web — How Vancomycin 50 MG/ML Oral Solution Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Vancomycin 50 MG/ML Oral Solution
RxCUI 2000134 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Vancomycin
11124IN
-
Vancomycin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Firvanq
2000128BN
-
Firvanq
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Vancomycin Oral Solution
374282SCDF -
Vancomycin Oral Liquid Product
1160500SCDG -
Vancomycin Oral Product
1160501SCDG -
Vancomycin Oral Solution [Firvanq]
2000130SBDF -
Firvanq Oral Liquid Product
2000131SBDG -
Firvanq Oral Product
2000132SBDG -
Oral Solution
316968DF -
Oral Liquid Product
1151137DFG - +1 more in this family
-
Vancomycin Oral Solution
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Vancomycin 50 MG/ML
328858SCDC -
Vancomycin 50 MG/ML Oral Solution [Firvanq]
2000136SBD -
Vancomycin 50 MG/ML [Firvanq]
2000135SBDC
-
Vancomycin 50 MG/ML
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Vancomycin 50 MG/ML
SCDC · 328858 -
Vancomycin Oral Solution
SCDF · 374282 -
Vancomycin Oral Liquid Product
SCDG · 1160500 -
Vancomycin Oral Product
SCDG · 1160501
Brand-Name Concepts
-
Vancomycin 50 MG/ML Oral Solution [Firvanq]
SBD · 2000136 -
Vancomycin 50 MG/ML [Firvanq]
SBDC · 2000135 -
Vancomycin Oral Solution [Firvanq]
SBDF · 2000130 -
Firvanq Oral Liquid Product
SBDG · 2000131 -
Firvanq Oral Product
SBDG · 2000132 -
Firvanq
BN · 2000128
📦 FDA Products & Package NDCs
18 products · 26 package NDCs
26 package NDCs map to RxCUI 2000134 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 52536-0104-05 | 1 KIT in 1 CARTON (52536-104-05) * 3.75 g in 1 BOTTLE (525... | Vancomycin Hydrochloride for Oral Solution | Wilshire Pharmaceuticals, Inc. | 2023-03-31 |
| 52536-0106-05 | 1 KIT in 1 CARTON (52536-106-05) * 7.5 g in 1 BOTTLE (5253... | Vancomycin Hydrochloride for Oral Solution | Wilshire Pharmaceuticals, Inc. | 2023-03-31 |
| 52536-0107-10 | 1 KIT in 1 CARTON (52536-107-10) * 295 mL in 1 BOTTLE (525... | Vancomycin Hydrochloride for Oral Solution | Wilshire Pharmaceuticals, Inc. | 2023-03-31 |
| 52536-0108-10 | 1 KIT in 1 CARTON (52536-108-10) * 289 mL in 1 BOTTLE (525... | Vancomycin Hydrochloride for Oral Solution | Wilshire Pharmaceuticals, Inc. | 2023-03-31 |
| 62559-0830-03 | 300 mL in 1 BOTTLE, PLASTIC (62559-830-03) | Vancomycin Hydrochloride | ANI Pharmaceuticals, Inc. | 2019-09-09 |
| 62559-0830-55 | 150 mL in 1 BOTTLE, PLASTIC (62559-830-55) | Vancomycin Hydrochloride | ANI Pharmaceuticals, Inc. | 2019-09-09 |
| 62559-0830-80 | 80 mL in 1 BOTTLE, PLASTIC (62559-830-80) | Vancomycin Hydrochloride | ANI Pharmaceuticals, Inc. | 2019-09-09 |
| 63629-1970-01 | 80 mL in 1 BOTTLE (63629-1970-1) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2019-09-09 |
| 63629-1971-01 | 150 mL in 1 BOTTLE (63629-1971-1) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2019-09-09 |
| 63629-1972-01 | 300 mL in 1 BOTTLE (63629-1972-1) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2019-09-09 |
| 65628-0204-05 | 1 KIT in 1 CARTON (65628-204-05) * 3.75 g in 1 BOTTLE * 1... | FIRVANQ | Azurity Pharmaceuticals, Inc | 2018-01-26 |
| 65628-0205-10 | 1 KIT in 1 CARTON (65628-205-10) * 7.5 g in 1 BOTTLE * 29... | FIRVANQ | Azurity Pharmaceuticals, Inc | 2018-01-26 |
| 65628-0206-05 | 1 KIT in 1 CARTON (65628-206-05) * 7.5 g in 1 BOTTLE * 14... | FIRVANQ | Azurity Pharmaceuticals, Inc | 2018-01-26 |
| 65628-0208-10 | 1 KIT in 1 CARTON (65628-208-10) * 15 g in 1 BOTTLE * 289... | FIRVANQ | Azurity Pharmaceuticals, Inc | 2018-01-26 |
| 67877-0750-58 | 1 KIT in 1 CARTON (67877-750-58) * 7.5 g in 1 BOTTLE * 29... | VANCOMYCIN HYDROCHLORIDE | Ascend Laboratories, LLC | 2023-08-01 |
| 67877-0750-81 | 1 KIT in 1 CARTON (67877-750-81) * 7.5 g in 1 BOTTLE * 29... | VANCOMYCIN HYDROCHLORIDE | Ascend Laboratories, LLC | 2023-08-01 |
| 67877-0751-58 | 1 KIT in 1 CARTON (67877-751-58) * 145 mL in 1 BOTTLE * 1... | VANCOMYCIN HYDROCHLORIDE | Ascend Laboratories, LLC | 2023-08-01 |
| 67877-0751-81 | 1 KIT in 1 CARTON (67877-751-81) * 145 mL in 1 BOTTLE * 1... | VANCOMYCIN HYDROCHLORIDE | Ascend Laboratories, LLC | 2023-08-01 |
| 69238-2261-03 | 80 mL in 1 BOTTLE (69238-2261-3) | Vancomycin Hydrochloride | Amneal Pharmaceuticals NY LLC | 2023-06-26 |
| 69238-2261-05 | 300 mL in 1 BOTTLE (69238-2261-5) | Vancomycin Hydrochloride | Amneal Pharmaceuticals NY LLC | 2023-06-26 |
| 69238-2261-07 | 150 mL in 1 BOTTLE (69238-2261-7) | Vancomycin Hydrochloride | Amneal Pharmaceuticals NY LLC | 2023-06-26 |
| 71335-2948-01 | 80 mL in 1 BOTTLE (71335-2948-1) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2025-11-06 |
| 71335-2950-01 | 150 mL in 1 BOTTLE (71335-2950-1) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2025-11-05 |
| 72162-1775-02 | 150 mL in 1 BOTTLE, PLASTIC (72162-1775-2) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2023-09-27 |
| 72162-1775-04 | 300 mL in 1 BOTTLE, PLASTIC (72162-1775-4) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2023-09-27 |
| 72162-1775-07 | 80 mL in 1 BOTTLE, PLASTIC (72162-1775-7) | Vancomycin Hydrochloride | Bryant Ranch Prepack | 2023-09-27 |
Observed labelers:
Bryant Ranch Prepack (8) ·
Ascend Laboratories, LLC (4) ·
Azurity Pharmaceuticals, Inc (4) ·
Wilshire Pharmaceuticals, Inc. (4) ·
Amneal Pharmaceuticals NY LLC (3) ·
ANI Pharmaceuticals, Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.